世界のしらみ治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pediculosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5296
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、しらみ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（しらみ寄生症、ケジラミ症、しらみ寄生症）、用途別市場規模（病院、クリニック、在宅治療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・しらみ治療の市場動向
・企業の競争状況、市場シェア
・しらみ治療の種類別市場規模と予測2016-2027（しらみ寄生症、ケジラミ症、しらみ寄生症）
・しらみ治療の用途別市場規模と予測2016-2027（病院、クリニック、在宅治療、その他）
・しらみ治療の北米市場規模2016-2027（アメリカ、カナダ）
・しらみ治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・しらみ治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・しらみ治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・しらみ治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（American Vanguard Corporation(TyraTech, Inc.)、Tec Laboratories Inc.、Arbor Pharmaceuticals LLC、Logic Product Group、The Harvard Drug Group(Major Pharmaceuticals)、ParaPRO, LLC、Prestige Consumer Healthcare, Inc.、Bayer AG、STADA Arzneimittel AG(Thornton & Ross)、Lavipharm）
・結論

Pediculosis is induced by infestation of blood feeding Phthiraptera as well as an ectoparasitic insect Louse.

Market Analysis and Insights: Global Pediculosis Treatment Market
The global Pediculosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediculosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediculosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediculosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediculosis Treatment market.

Global Pediculosis Treatment Scope and Market Size
Pediculosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediculosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
by Louse Type
Pediculosis Capitis
Pediculosis Pubis
Pediculosis Corporis
by Treatment
Dimeticone Lotion
Isopropyl Alcohol
Suffocation-Based Pediculicide
Petrolatum
Mercuric Oxide Ointment
Others

Segment by Application
Hospitals
Clinics
Home Care
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
American Vanguard Corporation(TyraTech, Inc.)
Tec Laboratories Inc.
Arbor Pharmaceuticals LLC
Logic Product Group
The Harvard Drug Group(Major Pharmaceuticals)
ParaPRO, LLC
Prestige Consumer Healthcare, Inc.
Bayer AG
STADA Arzneimittel AG(Thornton & Ross)
Lavipharm

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediculosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pediculosis Capitis
1.2.3 Pediculosis Pubis
1.2.4 Pediculosis Corporis
1.3 Market by Application
1.3.1 Global Pediculosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pediculosis Treatment Market Perspective (2016-2027)
2.2 Pediculosis Treatment Growth Trends by Regions
2.2.1 Pediculosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pediculosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pediculosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pediculosis Treatment Industry Dynamic
2.3.1 Pediculosis Treatment Market Trends
2.3.2 Pediculosis Treatment Market Drivers
2.3.3 Pediculosis Treatment Market Challenges
2.3.4 Pediculosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pediculosis Treatment Players by Revenue
3.1.1 Global Top Pediculosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Pediculosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pediculosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pediculosis Treatment Revenue
3.4 Global Pediculosis Treatment Market Concentration Ratio
3.4.1 Global Pediculosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediculosis Treatment Revenue in 2020
3.5 Pediculosis Treatment Key Players Head office and Area Served
3.6 Key Players Pediculosis Treatment Product Solution and Service
3.7 Date of Enter into Pediculosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pediculosis Treatment Breakdown Data by Type
4.1 Global Pediculosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pediculosis Treatment Forecasted Market Size by Type (2022-2027)

5 Pediculosis Treatment Breakdown Data by Application
5.1 Global Pediculosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pediculosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pediculosis Treatment Market Size (2016-2027)
6.2 North America Pediculosis Treatment Market Size by Type
6.2.1 North America Pediculosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Pediculosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Pediculosis Treatment Market Size by Type (2016-2027)
6.3 North America Pediculosis Treatment Market Size by Application
6.3.1 North America Pediculosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Pediculosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Pediculosis Treatment Market Size by Application (2016-2027)
6.4 North America Pediculosis Treatment Market Size by Country
6.4.1 North America Pediculosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Pediculosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pediculosis Treatment Market Size (2016-2027)
7.2 Europe Pediculosis Treatment Market Size by Type
7.2.1 Europe Pediculosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pediculosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pediculosis Treatment Market Size by Type (2016-2027)
7.3 Europe Pediculosis Treatment Market Size by Application
7.3.1 Europe Pediculosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pediculosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pediculosis Treatment Market Size by Application (2016-2027)
7.4 Europe Pediculosis Treatment Market Size by Country
7.4.1 Europe Pediculosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pediculosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pediculosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pediculosis Treatment Market Size by Type
8.2.1 Asia-Pacific Pediculosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pediculosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pediculosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pediculosis Treatment Market Size by Application
8.3.1 Asia-Pacific Pediculosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pediculosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pediculosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pediculosis Treatment Market Size by Region
8.4.1 Asia-Pacific Pediculosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pediculosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pediculosis Treatment Market Size (2016-2027)
9.2 Latin America Pediculosis Treatment Market Size by Type
9.2.1 Latin America Pediculosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pediculosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pediculosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Pediculosis Treatment Market Size by Application
9.3.1 Latin America Pediculosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pediculosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pediculosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Pediculosis Treatment Market Size by Country
9.4.1 Latin America Pediculosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pediculosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pediculosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pediculosis Treatment Market Size by Type
10.2.1 Middle East & Africa Pediculosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pediculosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pediculosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pediculosis Treatment Market Size by Application
10.3.1 Middle East & Africa Pediculosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pediculosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pediculosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pediculosis Treatment Market Size by Country
10.4.1 Middle East & Africa Pediculosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pediculosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 American Vanguard Corporation(TyraTech, Inc.)
11.1.1 American Vanguard Corporation(TyraTech, Inc.) Company Details
11.1.2 American Vanguard Corporation(TyraTech, Inc.) Business Overview
11.1.3 American Vanguard Corporation(TyraTech, Inc.) Pediculosis Treatment Introduction
11.1.4 American Vanguard Corporation(TyraTech, Inc.) Revenue in Pediculosis Treatment Business (2016-2021)
11.1.5 American Vanguard Corporation(TyraTech, Inc.) Recent Development
11.2 Tec Laboratories Inc.
11.2.1 Tec Laboratories Inc. Company Details
11.2.2 Tec Laboratories Inc. Business Overview
11.2.3 Tec Laboratories Inc. Pediculosis Treatment Introduction
11.2.4 Tec Laboratories Inc. Revenue in Pediculosis Treatment Business (2016-2021)
11.2.5 Tec Laboratories Inc. Recent Development
11.3 Arbor Pharmaceuticals LLC
11.3.1 Arbor Pharmaceuticals LLC Company Details
11.3.2 Arbor Pharmaceuticals LLC Business Overview
11.3.3 Arbor Pharmaceuticals LLC Pediculosis Treatment Introduction
11.3.4 Arbor Pharmaceuticals LLC Revenue in Pediculosis Treatment Business (2016-2021)
11.3.5 Arbor Pharmaceuticals LLC Recent Development
11.4 Logic Product Group
11.4.1 Logic Product Group Company Details
11.4.2 Logic Product Group Business Overview
11.4.3 Logic Product Group Pediculosis Treatment Introduction
11.4.4 Logic Product Group Revenue in Pediculosis Treatment Business (2016-2021)
11.4.5 Logic Product Group Recent Development
11.5 The Harvard Drug Group(Major Pharmaceuticals)
11.5.1 The Harvard Drug Group(Major Pharmaceuticals) Company Details
11.5.2 The Harvard Drug Group(Major Pharmaceuticals) Business Overview
11.5.3 The Harvard Drug Group(Major Pharmaceuticals) Pediculosis Treatment Introduction
11.5.4 The Harvard Drug Group(Major Pharmaceuticals) Revenue in Pediculosis Treatment Business (2016-2021)
11.5.5 The Harvard Drug Group(Major Pharmaceuticals) Recent Development
11.6 ParaPRO, LLC
11.6.1 ParaPRO, LLC Company Details
11.6.2 ParaPRO, LLC Business Overview
11.6.3 ParaPRO, LLC Pediculosis Treatment Introduction
11.6.4 ParaPRO, LLC Revenue in Pediculosis Treatment Business (2016-2021)
11.6.5 ParaPRO, LLC Recent Development
11.7 Prestige Consumer Healthcare, Inc.
11.7.1 Prestige Consumer Healthcare, Inc. Company Details
11.7.2 Prestige Consumer Healthcare, Inc. Business Overview
11.7.3 Prestige Consumer Healthcare, Inc. Pediculosis Treatment Introduction
11.7.4 Prestige Consumer Healthcare, Inc. Revenue in Pediculosis Treatment Business (2016-2021)
11.7.5 Prestige Consumer Healthcare, Inc. Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Details
11.8.2 Bayer AG Business Overview
11.8.3 Bayer AG Pediculosis Treatment Introduction
11.8.4 Bayer AG Revenue in Pediculosis Treatment Business (2016-2021)
11.8.5 Bayer AG Recent Development
11.9 STADA Arzneimittel AG(Thornton & Ross)
11.9.1 STADA Arzneimittel AG(Thornton & Ross) Company Details
11.9.2 STADA Arzneimittel AG(Thornton & Ross) Business Overview
11.9.3 STADA Arzneimittel AG(Thornton & Ross) Pediculosis Treatment Introduction
11.9.4 STADA Arzneimittel AG(Thornton & Ross) Revenue in Pediculosis Treatment Business (2016-2021)
11.9.5 STADA Arzneimittel AG(Thornton & Ross) Recent Development
11.10 Lavipharm
11.10.1 Lavipharm Company Details
11.10.2 Lavipharm Business Overview
11.10.3 Lavipharm Pediculosis Treatment Introduction
11.10.4 Lavipharm Revenue in Pediculosis Treatment Business (2016-2021)
11.10.5 Lavipharm Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pediculosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pediculosis Capitis
Table 3. Key Players of Pediculosis Pubis
Table 4. Key Players of Pediculosis Corporis
Table 5. Global Pediculosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pediculosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pediculosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pediculosis Treatment Market Share by Regions (2016-2021)
Table 9. Global Pediculosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pediculosis Treatment Market Share by Regions (2022-2027)
Table 11. Pediculosis Treatment Market Trends
Table 12. Pediculosis Treatment Market Drivers
Table 13. Pediculosis Treatment Market Challenges
Table 14. Pediculosis Treatment Market Restraints
Table 15. Global Pediculosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pediculosis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Pediculosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediculosis Treatment as of 2020)
Table 18. Ranking of Global Top Pediculosis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pediculosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pediculosis Treatment Product Solution and Service
Table 22. Date of Enter into Pediculosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pediculosis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Pediculosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pediculosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pediculosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pediculosis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Pediculosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pediculosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pediculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pediculosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pediculosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pediculosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pediculosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pediculosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pediculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pediculosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pediculosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pediculosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pediculosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pediculosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pediculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pediculosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pediculosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pediculosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pediculosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pediculosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pediculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pediculosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pediculosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pediculosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pediculosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pediculosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pediculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pediculosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pediculosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pediculosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pediculosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pediculosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. American Vanguard Corporation(TyraTech, Inc.) Company Details
Table 63. American Vanguard Corporation(TyraTech, Inc.) Business Overview
Table 64. American Vanguard Corporation(TyraTech, Inc.) Pediculosis Treatment Product
Table 65. American Vanguard Corporation(TyraTech, Inc.) Revenue in Pediculosis Treatment Business (2016-2021) & (US$ Million)
Table 66. American Vanguard Corporation(TyraTech, Inc.) Recent Development
Table 67. Tec Laboratories Inc. Company Details
Table 68. Tec Laboratories Inc. Business Overview
Table 69. Tec Laboratories Inc. Pediculosis Treatment Product
Table 70. Tec Laboratories Inc. Revenue in Pediculosis Treatment Business (2016-2021) & (US$ Million)
Table 71. Tec Laboratories Inc. Recent Development
Table 72. Arbor Pharmaceuticals LLC Company Details
Table 73. Arbor Pharmaceuticals LLC Business Overview
Table 74. Arbor Pharmaceuticals LLC Pediculosis Treatment Product
Table 75. Arbor Pharmaceuticals LLC Revenue in Pediculosis Treatment Business (2016-2021) & (US$ Million)
Table 76. Arbor Pharmaceuticals LLC Recent Development
Table 77. Logic Product Group Company Details
Table 78. Logic Product Group Business Overview
Table 79. Logic Product Group Pediculosis Treatment Product
Table 80. Logic Product Group Revenue in Pediculosis Treatment Business (2016-2021) & (US$ Million)
Table 81. Logic Product Group Recent Development
Table 82. The Harvard Drug Group(Major Pharmaceuticals) Company Details
Table 83. The Harvard Drug Group(Major Pharmaceuticals) Business Overview
Table 84. The Harvard Drug Group(Major Pharmaceuticals) Pediculosis Treatment Product
Table 85. The Harvard Drug Group(Major Pharmaceuticals) Revenue in Pediculosis Treatment Business (2016-2021) & (US$ Million)
Table 86. The Harvard Drug Group(Major Pharmaceuticals) Recent Development
Table 87. ParaPRO, LLC Company Details
Table 88. ParaPRO, LLC Business Overview
Table 89. ParaPRO, LLC Pediculosis Treatment Product
Table 90. ParaPRO, LLC Revenue in Pediculosis Treatment Business (2016-2021) & (US$ Million)
Table 91. ParaPRO, LLC Recent Development
Table 92. Prestige Consumer Healthcare, Inc. Company Details
Table 93. Prestige Consumer Healthcare, Inc. Business Overview
Table 94. Prestige Consumer Healthcare, Inc. Pediculosis Treatment Product
Table 95. Prestige Consumer Healthcare, Inc. Revenue in Pediculosis Treatment Business (2016-2021) & (US$ Million)
Table 96. Prestige Consumer Healthcare, Inc. Recent Development
Table 97. Bayer AG Company Details
Table 98. Bayer AG Business Overview
Table 99. Bayer AG Revenue in Pediculosis Treatment Business (2016-2021) & (US$ Million)
Table 100. Bayer AG Recent Development
Table 101. STADA Arzneimittel AG(Thornton & Ross) Company Details
Table 102. STADA Arzneimittel AG(Thornton & Ross) Business Overview
Table 103. STADA Arzneimittel AG(Thornton & Ross) Pediculosis Treatment Product
Table 104. STADA Arzneimittel AG(Thornton & Ross) Revenue in Pediculosis Treatment Business (2016-2021) & (US$ Million)
Table 105. STADA Arzneimittel AG(Thornton & Ross) Recent Development
Table 106. Lavipharm Company Details
Table 107. Lavipharm Business Overview
Table 108. Lavipharm Pediculosis Treatment Product
Table 109. Lavipharm Revenue in Pediculosis Treatment Business (2016-2021) & (US$ Million)
Table 110. Lavipharm Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediculosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Pediculosis Capitis Features
Figure 3. Pediculosis Pubis Features
Figure 4. Pediculosis Corporis Features
Figure 5. Global Pediculosis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Home Care Case Studies
Figure 9. Others Case Studies
Figure 10. Pediculosis Treatment Report Years Considered
Figure 11. Global Pediculosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Pediculosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pediculosis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Pediculosis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Pediculosis Treatment Market Share by Players in 2020
Figure 16. Global Top Pediculosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediculosis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pediculosis Treatment Revenue in 2020
Figure 18. Global Pediculosis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Pediculosis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Pediculosis Treatment Market Share by Type (2016-2027)
Figure 22. North America Pediculosis Treatment Market Share by Application (2016-2027)
Figure 23. North America Pediculosis Treatment Market Share by Country (2016-2027)
Figure 24. United States Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pediculosis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Pediculosis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Pediculosis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pediculosis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Pediculosis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Pediculosis Treatment Market Share by Region (2016-2027)
Figure 40. China Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pediculosis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Pediculosis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Pediculosis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pediculosis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Pediculosis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Pediculosis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Pediculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. American Vanguard Corporation(TyraTech, Inc.) Revenue Growth Rate in Pediculosis Treatment Business (2016-2021)
Figure 60. Tec Laboratories Inc. Revenue Growth Rate in Pediculosis Treatment Business (2016-2021)
Figure 61. Arbor Pharmaceuticals LLC Revenue Growth Rate in Pediculosis Treatment Business (2016-2021)
Figure 62. Logic Product Group Revenue Growth Rate in Pediculosis Treatment Business (2016-2021)
Figure 63. The Harvard Drug Group(Major Pharmaceuticals) Revenue Growth Rate in Pediculosis Treatment Business (2016-2021)
Figure 64. ParaPRO, LLC Revenue Growth Rate in Pediculosis Treatment Business (2016-2021)
Figure 65. Prestige Consumer Healthcare, Inc. Revenue Growth Rate in Pediculosis Treatment Business (2016-2021)
Figure 66. Bayer AG Revenue Growth Rate in Pediculosis Treatment Business (2016-2021)
Figure 67. STADA Arzneimittel AG(Thornton & Ross) Revenue Growth Rate in Pediculosis Treatment Business (2016-2021)
Figure 68. Lavipharm Revenue Growth Rate in Pediculosis Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の色汗症治療市場規模・現状・予測（2021年-2027年） Chromhidrosis is a rare condition characterized by the secretion of colored sweat. There are two types of glands such as apocrine and eccrine gland. Apocrine glands secrete a milky sweat that, once fragmented down by bacteria, is the main cause of body odor whereas Eccrine glands secrete an odorless…
世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界の物質使用障害治療市場規模・現状・予測（2021年-2027年） Drug addiction, also called substance use disorder, is a disease that affects a person's brain and behavior and leads to an inability to control the use of a legal or illegal drug or medication. Substances such as alcohol, marijuana and nicotine also are considered drugs. Market Analysis and Insight…
世界の小児喘息治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pediatric Asthma Treatment Market The global Pediatric Asthma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …
世界の睡眠麻痺治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sleep Paralysis Treatment Market The global Sleep Paralysis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…